Altimmune, Inc. (ALT)
3.56
-0.05
(-1.39%)
USD |
NASDAQ |
Dec 31, 14:46
Altimmune Market Cap: 371.46M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viking Therapeutics, Inc. | 3.946B |
| Amgen, Inc. | 176.60B |
| Rhythm Pharmaceuticals, Inc. | 7.169B |
| Terns Pharmaceuticals, Inc. | 3.610B |
| X4 Pharmaceuticals, Inc. | 349.75M |
Market Cap Related Metrics
| PS Ratio | 14137.83 |
| Price to Book Value | 2.001 |
| Price | 3.56 |
| Earnings Yield | -30.02% |